Cizzle Biotechnology strengthens North American rollout of CIZ1B lung cancer test (LON:CIZ) 2 October 2025
Ilika plc 2025 Review, Stereax Commercial Shipments, Goliath Scale-Up and Funding Progress 31 December 2025
Manx Financial Group New Overdraft Tech Partnership with Fiinu Plc Targets UK Liquidity Crunch (Video)
Roquefort Therapeutics secures exclusivity with Coiled Therapeutics RTO, eyeing AIM relist and NASDAQ (Video)
ICFG Ltd: Interim CEO Enkhmaral Batkhuyag Charts Bold Expansion with AI-Driven Finance and Insurtech Moves (Video)
Finseta Pushes Forward with Strategic Growth Plans Despite Interim Setback – Shore Capital 11 September 2025
Smith & Nephew outlines RISE strategy with upgraded guidance and new 2028 financial targets 8 December 2025
Workspace Group PLC (WKP.L) Stock Analysis: Navigating Potential Upside with a Strong Dividend Yield 9 January 2026
WH Smith PLC (SMWH.L) Stock Analysis: Navigating the Retail Landscape with a 19% Upside Potential 9 January 2026
Zigup PLC (ZIG.L) Stock Analysis: Growth Potential with a 26% Upside and Solid Dividend Yield 9 January 2026
Worldwide Healthcare Trust PLC (WWH.L) Stock Analysis: Strong Technicals Amid Limited Financial Visibility 9 January 2026
XPS Pensions Group (XPS.L) Investor Outlook: Navigating a 31.46% Potential Upside with Strong Buy Ratings 9 January 2026
Cizzle Biotechnology strengthens North American rollout of CIZ1B lung cancer test (LON:CIZ) 2 October 2025
Ilika plc 2025 Review, Stereax Commercial Shipments, Goliath Scale-Up and Funding Progress 31 December 2025
Manx Financial Group New Overdraft Tech Partnership with Fiinu Plc Targets UK Liquidity Crunch (Video)
Roquefort Therapeutics secures exclusivity with Coiled Therapeutics RTO, eyeing AIM relist and NASDAQ (Video)
ICFG Ltd: Interim CEO Enkhmaral Batkhuyag Charts Bold Expansion with AI-Driven Finance and Insurtech Moves (Video)
Finseta Pushes Forward with Strategic Growth Plans Despite Interim Setback – Shore Capital 11 September 2025
Smith & Nephew outlines RISE strategy with upgraded guidance and new 2028 financial targets 8 December 2025
Workspace Group PLC (WKP.L) Stock Analysis: Navigating Potential Upside with a Strong Dividend Yield 9 January 2026
WH Smith PLC (SMWH.L) Stock Analysis: Navigating the Retail Landscape with a 19% Upside Potential 9 January 2026
Zigup PLC (ZIG.L) Stock Analysis: Growth Potential with a 26% Upside and Solid Dividend Yield 9 January 2026
Worldwide Healthcare Trust PLC (WWH.L) Stock Analysis: Strong Technicals Amid Limited Financial Visibility 9 January 2026
XPS Pensions Group (XPS.L) Investor Outlook: Navigating a 31.46% Potential Upside with Strong Buy Ratings 9 January 2026
Compass Therapeutics, Inc. (CMPX) Stock Analysis: A 275% Potential Upside in the Biotechnology Sector 11 September 2025
Neurogene Inc. (NGNE) Stock Analysis: Exploring a Potential 154.84% Upside in the Biotech Sector 11 September 2025
TotalEnergies SE (TTE) Investor Outlook: Unpacking a Potential 11% Upside in the Energy Sector 11 September 2025
Palvella Therapeutics, Inc. (PVLA) Investor Outlook: A Biotech Stock with Strong Analyst Buy Ratings and Impressive Growth Trajectory 11 September 2025
ClearPoint Neuro Inc. (CLPT) Stock Analysis: A Strong Buy with 175% Upside Potential 11 September 2025
Viemed Healthcare, Inc. (VMD) Stock Analysis: A 96.97% Potential Upside Grabs Investor Attention 11 September 2025
Canopy Growth Corporation (CGC): Investor Outlook Amidst Revenue Growth and Valuation Challenges 11 September 2025
Health Catalyst, Inc (HCAT) Stock Analysis: Exploring a 39.74% Upside Potential in Healthcare Analytics 11 September 2025
iTeos Therapeutics, Inc. (ITOS) Stock Analysis: Navigating the Biotechnology Landscape with Strategic Immuno-Oncology Innovations 11 September 2025
TruBridge, Inc. (TBRG) Stock Analysis: Exploring a 24.37% Potential Upside Amid Healthcare Tech Advancements 11 September 2025
CytomX Therapeutics, Inc. (CTMX) Investor Outlook: Exploring the 177.78% Potential Upside in Biotech Innovation 11 September 2025
Rigel Pharmaceuticals, Inc. (RIGL) Stock Analysis: Exploring a 176% Revenue Growth with Strategic Collaborations 11 September 2025
Candel Therapeutics, Inc. (CADL) Stock Analysis: 305% Potential Upside Captures Investor Interest 11 September 2025
Pacific Biosciences of California (PACB) Stock Analysis: Exploring a Potential 73% Upside 11 September 2025
Abeona Therapeutics Inc. (ABEO) Stock Analysis: A Promising 213.94% Upside in the Biotechnology Sector 11 September 2025
Firering Strategic Minerals Kiln Upgrades, Hydration Circuit and Untapped Margin Potential (Video) 23 September 2025
Acuity RM Group CEO David Rajakovich Unveils AI-Driven Turnaround and New Growth Strategy (Video) 19 September 2025
Manx Financial Group New Overdraft Tech Partnership with Fiinu Plc Targets UK Liquidity Crunch (Video) 18 September 2025
Roquefort Therapeutics secures exclusivity with Coiled Therapeutics RTO, eyeing AIM relist and NASDAQ (Video) 11 September 2025
ICFG Ltd: Interim CEO Enkhmaral Batkhuyag Charts Bold Expansion with AI-Driven Finance and Insurtech Moves (Video) 10 September 2025
ZIGUP reports higher underlying revenue and stronger rental performance in HY results 3 December 2025
Cizzle Biotechnology strengthens North American rollout of CIZ1B lung cancer test (LON:CIZ) 2 October 2025
Finseta Pushes Forward with Strategic Growth Plans Despite Interim Setback – Shore Capital 11 September 2025
Ilika plc 2025 Review, Stereax Commercial Shipments, Goliath Scale-Up and Funding Progress 31 December 2025
Workspace Group PLC (WKP.L) Stock Analysis: Navigating Potential Upside with a Strong Dividend Yield 9 January 2026
WH Smith PLC (SMWH.L) Stock Analysis: Navigating the Retail Landscape with a 19% Upside Potential 9 January 2026
Zigup PLC (ZIG.L) Stock Analysis: Growth Potential with a 26% Upside and Solid Dividend Yield 9 January 2026
Worldwide Healthcare Trust PLC (WWH.L) Stock Analysis: Strong Technicals Amid Limited Financial Visibility 9 January 2026
XPS Pensions Group (XPS.L) Investor Outlook: Navigating a 31.46% Potential Upside with Strong Buy Ratings 9 January 2026
